Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028

Published by Inkwood Research Product code 953130
Published Content info 102 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028
Published: August 10, 2020 Content info: 102 Pages
Description

KEY FINDINGS

The Europe extra corporeal membrane oxygenation (ECMO) system market is estimated to project a CAGR of 4.54%, during the forecast period, 2019-2028. The advanced healthcare infrastructure and the growing utilization of ECMO are the factors fueling market growth.

MARKET INSIGHTS

The Europe extra corporeal membrane oxygenation (ECMO) system market growth analysis entails the assessment of Italy, Poland, the United Kingdom, France, Germany, Russia, Belgium, and the rest of Europe. Germany has witnessed the widespread progress of ECMO in the care of critically ill, along with growing utilization in cardiac and respiratory support. Cardiovascular disease cases are piling up in the country, and is one of the leading cause of death. The number of reported deaths stood at 1,28,1230, in 2015, as per the WHO report. ECMO can potentially minimize the number of death rates. Around 48,000 heart bypasses were conducted in the country, according to the Eurostat 2019 report. The population undergoing cardiopulmonary bypass procedures is rising, which calls for increased use of ECMO.

In Italy, almost 5.59% of deaths in 2018 were due to lung disease. Also, as per WHO, almost 2.4 million population had heart diseases. ECMOnet is a national referral network set up by the health authorities. It comprises advanced respiratory care that includes ECCO2R and ECMO, for acute respiratory distress syndrome patients. Such aspects influence the scope of the market studied. The country is also set to be one of the major contributors to the European market.

COMPETITIVE INSIGHTS

Some of the renowned companies present in the market are Terumo Medical Corporation, Origen Biomedical Inc, Nipro Corporation, Microport Scientific CorporationSpectrum Medical, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 33021

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASED USAGE OF ECMO TECHNOLOGY
    • 3.2.2. TECHNOLOGICAL ADVANCEMENT
    • 3.2.3. GROWING BURDEN OF CHRONIC DISORDERS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF SPECIALIZED EXPERTISE
    • 3.3.2. HIGH COST OF ECMO SYSTEM
    • 3.3.3. SIDE EFFECTS RELATED TO THE ECMO SYSTEM
    • 3.3.4. PRESENCE OF CONVENTIONAL TECHNIQUES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY MODALITY

  • 5.1. VENO-VENOUS
  • 5.2. VENO-ARTERIAL
  • 5.3. OTHER MODALITIES

6. MARKET BY APPLICATION

  • 6.1. RESPIRATORY
  • 6.2. CARDIAC
  • 6.3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. THE UNITED KINGDOM
    • 7.1.2. GERMANY
    • 7.1.3. FRANCE
    • 7.1.4. ITALY
    • 7.1.5. RUSSIA
    • 7.1.6. BELGIUM
    • 7.1.7. POLAND
    • 7.1.8. REST OF EUROPE

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. ALUNG TECHNOLOGIES INC
  • 8.3. ELSIUS BIOMEDICAL INC
  • 8.4. EUROSETS
  • 8.5. GETINGE AB
  • 8.6. LIVANOVA PLC
  • 8.7. MEDTRONIC PLC
  • 8.8. MICROPORT SCIENTIFIC CORPORATION
  • 8.9. NIPRO CORPORATION
  • 8.10. ORIGEN BIOMEDICAL INC
  • 8.11. SPECTRUM MEDICAL
  • 8.12. TERUMO MEDICAL CORPORATION
  • 8.13. XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM
  • TABLE 2: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIST OF CHRONIC DISEASES
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019
  • FIGURE 7: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019
  • FIGURE 11: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: THE UNITED KINGDOM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GERMANY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 17: FRANCE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 18: ITALY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 19: RUSSIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 20: BELGIUM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 21: POLAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 22: REST OF EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
Back to Top